ADC Therapeutics Statistics
Total Valuation
ADCT has a market cap or net worth of $401.74 million. The enterprise value is $290.35 million.
| Market Cap | 401.74M |
| Enterprise Value | 290.35M |
Important Dates
The last earnings date was Monday, May 6, 2024, before market open.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ADCT has 96.23 million shares outstanding. The number of shares has increased by 2.16% in one year.
| Shares Outstanding | 96.23M |
| Shares Change (YoY) | +2.16% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 20.80% |
| Owned by Institutions (%) | 40.41% |
| Float | 63.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.85 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.61
| Current Ratio | 4.61 |
| Quick Ratio | 4.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -55.50% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $251,352 |
| Profits Per Employee | -$832,355 |
| Employee Count | 273 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 0.26 |
Taxes
In the past 12 months, ADCT has paid $39.53 million in taxes.
| Income Tax | 39.53M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +54.72% in the last 52 weeks. The beta is 1.74, so ADCT's price volatility has been higher than the market average.
| Beta (1Y) | 1.74 |
| 52-Week Price Change | +54.72% |
| 50-Day Moving Average | 4.49 |
| 200-Day Moving Average | 2.45 |
| Relative Strength Index (RSI) | 42.80 |
| Average Volume (30 Days) | 592,550 |
Short Selling Information
The latest short interest is 857,607, so 0.89% of the outstanding shares have been sold short.
| Short Interest | 857,607 |
| Short Previous Month | 993,081 |
| Short % of Shares Out | 0.89% |
| Short % of Float | 1.36% |
| Short Ratio (days to cover) | 1.89 |
Income Statement
In the last 12 months, ADCT had revenue of $68.62 million and -$227.23 million in losses. Loss per share was -$2.77.
| Revenue | 68.62M |
| Gross Profit | 64.17M |
| Operating Income | -148.03M |
| Pretax Income | -187.70M |
| Net Income | -227.23M |
| EBITDA | -135.32M |
| EBIT | -138.73M |
| Loss Per Share | -$2.77 |
Balance Sheet
The company has $234.29 million in cash and $122.90 million in debt, giving a net cash position of $111.39 million or $1.16 per share.
| Cash & Cash Equivalents | 234.29M |
| Total Debt | 122.90M |
| Net Cash | 111.39M |
| Net Cash Per Share | $1.16 |
| Equity / Book Value | -194.45M |
| Book Value Per Share | -2.02 |
| Working Capital | 227.22M |
Cash Flow
In the last 12 months, operating cash flow was -$154.12 million and capital expenditures -$2.73 million, giving a free cash flow of -$156.85 million.
| Operating Cash Flow | -154.12M |
| Capital Expenditures | -2.73M |
| Free Cash Flow | -156.85M |
| FCF Per Share | -$1.90 |
Margins
Gross margin is 93.52%, with operating and profit margins of -215.72% and -331.15%.
| Gross Margin | 93.52% |
| Operating Margin | -215.72% |
| Pretax Margin | -273.54% |
| Profit Margin | -331.15% |
| EBITDA Margin | -197.20% |
| EBIT Margin | -202.18% |
| FCF Margin | -228.58% |
Dividends & Yields
ADCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.16% |
| Shareholder Yield | -2.16% |
| Earnings Yield | -56.56% |
| FCF Yield | -39.04% |
Analyst Forecast
The average price target for ADCT is $7.00, which is 70.73% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.00 |
| Price Target Difference | 70.73% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 34.54% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADCT has an Altman Z-Score of -6.18 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.18 |
| Piotroski F-Score | 1 |